Skip to main content
. 2021 Jul 13;14:11795514211030513. doi: 10.1177/11795514211030513

Table 4.

HbA1c level wise treatment distribution.

Characteristics Group A, <7.5% (n = 835)* Group B, ⩾7.5 to ⩽8.5% (n = 3605)** Group C, >8.5% (n = 1119) # P value
Age (y) 49.0 (42.0-59.0) [n = 3599] 49 (41.0-58.0) 47.0 (55.0-63.0) .092 a , .001b,c
Age group (y), n (%)
 ⩾20-⩽40 179 (21.4) 889 (24.7) 128 (11.4) <.001a,b,c
 >40-⩽60 490 (58.7) 2067 (57.4) 648 (57.4)
 >60-⩽80 166 (19.9) 643 (17.9) 343 (30.7)
Sex, n (%) [n = 803] [n = 3518] [n = 1102] .186
 Men 480 (59.8) 2216 (63.0) 700 (63.5)
 Women 323 (40.2) 1302 (37.0) 402 (36.5)
BMI (kg/m2) [n = 742] 26.7 (24.3-29.5) [n = 3183] 27.7 (25.3-30.4) [n = 998] 28.7 (26.0-31.0) <.001a,b,c
Location, n (%) [n = 600] [n = 2736] [n = 760] .137
 Urban 124 (20.7) 598 (21.9) 141 (18.6)
 Rural 476 (79.3) 2138 (78.1) 619 (81.4)
Duration of diabetes (mo) [n = 829] 36.0 (12.0-60.0) [n = 3581] 36.0 (12.0-72.0) [n = 1112] 60.0 (24.0-96.0) <.001a,b,c
Duration of high-dose treatment (mo) [n = 692] 12.0 (6.0-24.0) [n = 3397] 20.0 (6.0-36.0) [n = 987] 24.0 (12.0-48.0) .005 a , <0.001b,c
Mean HbA1c level (%) [n = 301] [n = 1481] [n = 417]
 Previous 7.5 (0.6) 8.1 (0.6) 9.3 (0.8)
 Current 6.6 (0.5) 7.1 (0.6) 7.8 (0.8)
 Mean change [95% CI]; P value 0.9 [0.8-0.9]; <.001 1.0 [1.0-1.1]; <.001 1.4 [1.3-1.4]; <.001
Weight change (kg), n (%) [n = 599] [n = 2728] [n = 793]
 Increase
  0-2 109 (18.2) 239 (8.7) 96 (12.9)
  2-4 28 (4.7) 151 (5.5) 54 (6.8)
  >4 0 13 (0.5) 10 (1.3)
 Decrease
  0-2 314 (52.4) 1708 (62.6) 349 (44.0)
  2-4 134 (22.4) 541(19.8) 215 (27.1)
  >4 14 (2.3) 76 (2.7) 69 (8.7)

Abbreviations: BMI, body mass index; HbA1c, glycated hemoglobin; IQR, interquartile range.

Data shown as median (IQR), unless otherwise specified.

a

Group A versus B; bgroup A versus C; cgroup B versus C.

*

n = 835. **n = 3605. #n = 1119, unless otherwise specified.